Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Project 1 Aim 2 and 3
1 other identifier
observational
15
1 country
1
Brief Summary
This study will test the hypothesis that deep brain stimulation (DBS) targeting specific changes in oscillatory activity at the site of stimulation will prove superior to continuous isochronal DBS thus providing the rationale for development and optimization of closed loop paradigms and determine whether the optimal closed-loop biomarker varies across subcortical targets, is task dependent, or serves to re-establish a default network that removes an underlying disruptive physiological state leading to greater improvement in motor signs and task performance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2017
CompletedFirst Posted
Study publicly available on registry
March 14, 2017
CompletedStudy Start
First participant enrolled
June 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 29, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 29, 2023
CompletedApril 16, 2024
April 1, 2024
4.6 years
February 24, 2017
April 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Measure local field potential (LFP) changes in subthalamic nucleus (STN) and globus pallidus (GP) in OFF and ON states of stimulation and medication
Clinical ratings scales (MDS-UPDRS)
2 days
Study Arms (1)
Stimulation
Traditional deep brain stimulation
Interventions
Eligibility Criteria
Parkinson's Disease (PD)
You may qualify if:
- Diagnosis of idiopathic PD
- DBS surgery or IPG battery replacement at UMN is planned as part of routine clinical care.
You may not qualify if:
- Other significant neurological disorder
- History of dementia
- Prior history of stereotactic neurosurgery
- Patients with post-operative complications or adverse effects (e.g. ON stimulation dystonias) that affect patient safety or confound the experiment will be excluded from further study
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota Medical Center
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael C. Park, MD/PhD
University of Minnesota
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2017
First Posted
March 14, 2017
Study Start
June 19, 2018
Primary Completion
January 29, 2023
Study Completion
January 29, 2023
Last Updated
April 16, 2024
Record last verified: 2024-04